IL33 and colitis: Imaeda et al. also reported an exacerbation of DSS-induced colitis upon treatment with IL-33, hypothesized to occur by IL-33-dependent induction of pathogenic Th2 cytokines; although in the same mice, IL-33 restored goblet cells that were found to be depleted in IL-33-untreated mice[43].